Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001144204-13-053927)

Filing Details

Accession Number:: 0001144204-13-053927
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-03 21:32:01
Reporting Period:: 2013-10-01

Filing Date:: 2013-10-03
Accepted Time:: 2013-10-03 21:32:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1270073	Intercept Pharmaceuticals Inc	ICPT	Pharmaceutical Preparations (2834)	223868459

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1283972	Dr R Klaus Veitinger	C/O Intercept Pharmaceuticals, Inc. 18 Desbrosses Street New York NY 10013		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2013-10-01	100	$69.26	2,528	No	4	S	Direct
Common Stock	Disposition	2013-10-01	100	$72.64	2,428	No	4	S	Direct
Common Stock	Disposition	2013-10-01	100	$73.57	2,328	No	4	S	Direct
Common Stock	Disposition	2013-10-01	100	$74.25	2,228	No	4	S	Direct
Common Stock	Disposition	2013-10-01	100	$74.77	2,128	No	4	S	Direct
Common Stock	Disposition	2013-10-01	100	$74.89	2,028	No	4	S	Direct
Common Stock	Disposition	2013-10-01	71	$75.00	1,957	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on June 26, 2013.